Actively Recruiting
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Led by The University of Texas Health Science Center at San Antonio · Updated on 2026-01-08
84
Participants Needed
1
Research Sites
428 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.
CONDITIONS
Official Title
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically or radiographically (CT or MRI) confirmed newly diagnosed hepatocellular carcinoma.
- Age 18 years and older.
- Patients with advanced, unresectable HCC as determined by the treating physician.
You will not qualify if you...
- Patients with resectable HCC who are still candidates for locoregional therapy
- Patients receiving prior systemic or locoregional therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mays Cancer Center
San Antonio, Texas, United States, 78229
Actively Recruiting
Research Team
M
Maggie Tomasini, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here